论文部分内容阅读
应用静脉输注免疫球蛋白（ＩＶＩＧ）治疗小儿原发性血小板减少性紫癜（ＩＴＰ）２０例。有效率为８５％（１７／２０），出血症状迅速控制，血小板计数２周内上升到正常水平。同时检测了治疗前后血清可溶性白细胞介素Ⅱ受体（ＳＩＬ—２Ｒ），结果提示：ＩＶＩＧ对ＩＴＰ的治疗作用可能与其调节免疫功能有关
The application of intravenous infusion of immunoglobulin (IVIG) in children with thrombocytopenic purpura (ITP) in 20 cases. Efficacy was 85% (17/20), rapid control of bleeding symptoms, platelet count rose to normal within 2 weeks. Simultaneous detection of serum soluble interleukin-2 receptor (SIL-2R) before and after treatment showed that the therapeutic effect of IVIG on ITP may be related to the regulation of immune function